mRNA-1283 encodes for the portions of the SARS-CoV-2 spike protein critical for neutralization, specifically the Receptor Binding Domain (RBD) and N-terminal Domain (NTD).
March 16, 2021
US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in…
January 25, 2021
COVID-19 Vaccine: Moderna said it expects to have approximately 20 million doses of the vaccine, called mRNA-1273, available in the US by the end of the year.
November 30, 2020
Moderna is already testing the higher dose in a large Phase III trial, the final stage before seeking emergency authorization or approval.
September 30, 2020
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19…
September 18, 2020
Brussels, Aug 25 : The European Commission concluded exploratory talks with Moderna, an American biotechnology company focused on…
August 25, 2020